Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer
2017 · Molecular Therapy — Nucleic Acids · 93 citations
https://doi.org/10.1016/j.omtn.2017.12.015
H
Hong Yan Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
71
Papers
980
Citations
16
h-index
19
i10-index
Hong Yan Liu is an academic researcher from Zhongyuan University of Technology. The author has contributed to research in topics: Advanced biosensing and bioanalysis techniques & RNA Interference and Gene Delivery & Electrospun Nanofibers in Biomedical Applications. The author has an h-index of 16, co-authored 61 publications.
ORCID: 0000-0001-6484-9896Papers by this author
worksCo-targeting EGFR and survivin with a bivalent aptamer-dual siRNA chimera effectively suppresses prostate cancer
2016 · Scientific Reports · 68 citations
https://doi.org/10.1038/srep30346
Polymorphism of A133S and promoter hypermethylation in Ras association domain family 1A gene (RASSF1A) is associated with risk of esophageal and gastric cardia cancers in Chinese population from high incidence area in northern China
2013 · BMC Cancer · 24 citations
https://doi.org/10.1186/1471-2407-13-259
Clinical and molecular cytogenetic analyses of four patients with imbalanced translocations
2016 · Molecular Cytogenetics · 5 citations
https://doi.org/10.1186/s13039-016-0244-x
Targeted Delivery of AR-V7 siRNA with Bivalent PSMA Aptamers Effectively Suppresses the Growth of Enzalutamide-Resistant Prostate Cancer
2024 · Molecular Pharmaceutics · 4 citations
https://doi.org/10.1021/acs.molpharmaceut.4c00743
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat